Benzinga | Jul 29, 2020 06:36AM EDT

Magellan Health Q2 Adj. EPS $0.84 Misses $0.98 Estimate, Sales $1.10B Miss $1.43B Estimate

Magellan Health (NASDAQ:MGLN) reported quarterly earnings of $0.84 per share which missed the analyst consensus estimate of $0.98 by 14.29 percent. This is a 2.33 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $1.10 billion which missed the analyst consensus estimate of $1.43 billion by 23.08 percent. This is a 38.48 percent decrease over sales of $1.79 billion the same period last year.